5 Key Takeaways From The GPhA Biosimilars Forum
Top policymakers, attorneys and pharmaceutical executives voiced predictions on upcoming regulation and litigation involving biosimilars at a high-profile conference staged by the Generic Pharmaceutical Association....To view the full article, register now.
Already a subscriber? Click here to view full article